CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0278
+0.0028 (11.20%)
May 20, 2025, 3:58 PM EDT
CV Sciences Employees
As of December 31, 2024, CV Sciences had 49 total employees, including 47 full-time and 2 part-time employees. The number of employees increased by 6 or 13.95% compared to the previous year.
Employees
49
Change (1Y)
6
Growth (1Y)
13.95%
Revenue / Employee
$318,938
Profits / Employee
-$39,063
Market Cap
5.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
CV Sciences News
- 5 days ago - Marijuana Stock Movers For May 15, 2025 - Benzinga
- 6 days ago - CV Sciences Non-GAAP EPS of $0.00, revenue of $3.6M - Seeking Alpha
- 6 days ago - CV Sciences targets cost efficiency gains and product diversification with in-source manufacturing and non-cannabinoid launches - Seeking Alpha
- 6 days ago - CV Sciences, Inc. (CVSI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - CV Sciences, Inc. Reports First Quarter 2025 Financial Results - Accesswire
- 11 days ago - CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025 - Accesswire
- 12 days ago - Marijuana Stock Movers For May 8, 2025 - Benzinga
- 6 weeks ago - Cannabis Stock Gainers And Losers From April 8, 2025 - Benzinga